Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
27.02.26
/
50%
€32.80
Target price
27.02.27
€93.24
Performance (%)
0.79%
Price
26.02.26
€34.08
Summary
This prediction is currently active. Since the start of the prediction for Soleno Therapeutics Inc. the price has only changed by 0.79%. This prediction currently runs until 27.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Soleno Therapeutics Inc. | 0.79% |
| iShares Core DAX® | 1.232% |
| iShares Nasdaq 100 | 0.695% |
| iShares Nikkei 225® | 2.085% |
| iShares S&P 500 | 0.419% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.65
20.08.25
20.08.25
€105.76
20.08.26
20.08.26
-42.65%
26.02.26
26.02.26

